Dermatologists who administer chemotherapy and other drugs in their offices could see significant reductions in reimbursement levels as a result of an effort by the federal government to curtail Medicare's costs for drugs used to treat cancer.
Is Your Texting as Caring as Your Bedside Manner?
The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice
Tax-Loss Harvesting: An Important Tactic Every Dermatologist Should Consider
Shanna Miranti, MPAS, PA-C, Shares Highlights From Diversity in Dermatology Meeting
Melanoma and the Wrong Site
Pre- and Postemployment Contract Review: Safeguard Your Interests